Biodexa Pharmaceuticals (BDRX) Net Margin Growth (1y) (2016 - 2020)
Powered by 
Analysis
Biodexa Pharmaceuticals (BDRX) Net Margin Growth (1y) (2016 - 2020) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 802.00 |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | -16,220.00 |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | -185.00 |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | -763.00 |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | 529.00 |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | 4,168.00 |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 2,208.00 |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | -2,043.00 |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | -753,036.00 |
| 10 | Biodexa Pharmaceuticals | 52.37 Mn | 41.02 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | -1.09 Mn |
| Dec 31, 2019 | -184,402.00 |
| Dec 31, 2018 | -22,141.00 |
| Dec 31, 2017 | 1,458.00 |
| Dec 31, 2016 | 11,089.00 |